168 related articles for article (PubMed ID: 22529897)
1. Dimethyl sulfoxide promotes the multiple functions of the tumor suppressor HLJ1 through activator protein-1 activation in NSCLC cells.
Wang CC; Lin SY; Lai YH; Liu YJ; Hsu YL; Chen JJ
PLoS One; 2012; 7(4):e33772. PubMed ID: 22529897
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.
Wang CC; Tsai MF; Dai TH; Hong TM; Chan WK; Chen JJ; Yang PC
Cancer Res; 2007 May; 67(10):4816-26. PubMed ID: 17510411
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.
Chen HW; Lee JY; Huang JY; Wang CC; Chen WJ; Su SF; Huang CW; Ho CC; Chen JJ; Tsai MF; Yu SL; Yang PC
Cancer Res; 2008 Sep; 68(18):7428-38. PubMed ID: 18794131
[TBL] [Abstract][Full Text] [Related]
4. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer.
Lai YH; Yu SL; Chen HY; Wang CC; Chen HW; Chen JJ
Carcinogenesis; 2013 May; 34(5):1069-80. PubMed ID: 23306212
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.
Chang TP; Yu SL; Lin SY; Hsiao YJ; Chang GC; Yang PC; Chen JJ
Cancer Res; 2010 Feb; 70(4):1656-67. PubMed ID: 20145123
[TBL] [Abstract][Full Text] [Related]
6. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion.
Wang CC; Tsai MF; Hong TM; Chang GC; Chen CY; Yang WM; Chen JJ; Yang PC
Oncogene; 2005 Jun; 24(25):4081-93. PubMed ID: 15782117
[TBL] [Abstract][Full Text] [Related]
8. HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma.
Lin SY; Hsueh CM; Yu SL; Su CC; Shum WY; Yeh KC; Chang GC; Chen JJ
Nucleic Acids Res; 2010 Oct; 38(18):6148-58. PubMed ID: 20494979
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
[TBL] [Abstract][Full Text] [Related]
10. HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.
Chen CH; Chang WH; Su KY; Ku WH; Chang GC; Hong QS; Hsiao YJ; Chen HC; Chen HY; Wu R; Yang PC; Chen JJ; Yu SL
Oncogene; 2016 Oct; 35(43):5674-5685. PubMed ID: 27065329
[TBL] [Abstract][Full Text] [Related]
11. Highly Expressed FOXF1 Inhibit Non-Small-Cell Lung Cancer Growth via Inducing Tumor Suppressor and G1-Phase Cell-Cycle Arrest.
Wu CY; Chan CH; Dubey NK; Wei HJ; Lu JH; Chang CC; Cheng HC; Ou KL; Deng WP
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370197
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells.
Zhang L; Cai X; Chen K; Wang Z; Wang L; Ren M; Huang A; Tang H
Virus Res; 2011 Apr; 157(1):76-81. PubMed ID: 21345358
[TBL] [Abstract][Full Text] [Related]
13. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
14. Acidic stress facilitates tyrosine phosphorylation of HLJ1 to associate with actin cytoskeleton in lung cancer cells.
Chen CH; Lin H; Chuang SM; Lin SY; Chen JJ
Exp Cell Res; 2010 Oct; 316(17):2910-21. PubMed ID: 20615403
[TBL] [Abstract][Full Text] [Related]
15. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
[TBL] [Abstract][Full Text] [Related]
17. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
[TBL] [Abstract][Full Text] [Related]
19. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]